Patient Guide: A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 15 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06675175
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Kidney Disease, Atherosclerotic Cardiovascular Disease
Phase: PHASE1

Where You Can Participate

This study is available at 15 locations across the country.

Top locations include:
  • • Glendale, California
  • • Daytona Beach, Florida
  • • Jacksonville, Florida
  • • And 12 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease. - Join Clinical Trial NCTNCT06675175

How to Join This Clinical Trial - NCTNCT06675175

Learn how to participate in this PHASE1 trial studying an investigational therapy for Chronic Kidney Disease, Atherosclerotic Cardiovascular Disease. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Kidney Disease, Atherosclerotic Cardiovascular Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Kidney Disease, Atherosclerotic Cardiovascular Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06675175 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 15 locations. Find a study site near you:

Clinical Research Site

Glendale, California 91203 - United States

Status: Contact for availability

Clinical Research Site

Daytona Beach, Florida 32117 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32216 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33125 - United States

Status: Contact for availability

Clinical Research Site

Port Orange, Florida 32127 - United States

Status: Contact for availability

Clinical Research Site

Tampa, Florida 33603 - United States

Status: Contact for availability

Clinical Research Site

Farmington Hills, Michigan 48334 - United States

Status: Contact for availability

Clinical Research Site

The Bronx, New York 10455 - United States

Status: Contact for availability

Clinical Research Site

Sherman, Texas 75092 - United States

Status: Contact for availability

Clinical Research Site

Pleven, 5800 - Bulgaria

Status: Contact for availability

And 5 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Chronic Kidney Disease, Atherosclerotic Cardiovascular Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships